Advertisement

Topics

Cell Medica Company Profile

11:22 EDT 19th September 2017 | BioPortfolio

Cell Medica is a clinical stage cellular therapeutics company engaged in the development and delivery of cellular immunotherapy treatment strategies for infectious disease and cancer. The Company’s lead clinical application, referred to as Virus-Specific Immune Reconstitution (VSIR), involves the transfer of donor-derived virus-specific T cells into a patient in order to prevent infections following allogeneic hematopoietic stem cell (bone marrow) transplant. The Company is currently sponsoring a confirmatory (Phase III style) clinical trial for VSIR across 14 bone marrow transplant centers in the UK.


News Articles [2150 Associated News Articles listed on BioPortfolio]

Cell Medica Acquires Catapult Therapy for WT1 Cancer Immunotherapy Candidate

LONDON–(BUSINESS WIRE)–Cell Medica today announced the acquisition of Catapult Therapy TCR Limited, a subsidiary of Cell and Gene Therapy Catapult (CGT Catapult), and the initiation of a c...

Cell Medica buys T cell receptor cancer candidate from UK Catapult

Cell Medica says it will work with the Cell and Gene Therapy Catapult to assess automation and processing technologies involved in scaling-up the acquired cancer candidate.

Cell Medica: Transforming patients live through cellular immunotherapy

Cell Medica is committed to transforming the treatment of cancer through the use of cellular immunotherapy. Through our internal development and collaborations and with leading academic research grou...

Cell Medica Acquires Catapult Therapy for Lead WT1-TCR T Cell Therapy

Cell Medica is buying Catapult Therapy TCR and the firm's gene-modified WT1-TCR T cell therapy candidate. The treatment is currently in Phase I/II development for the potential treatment of acute ...

Cell Medica Acquires Catapult Therapy for Lead WT1-TCR T-Cell Therapy

Cell Medica is buying Catapult Therapy TCR and the firm's gene-modified WT1-TCR T cell therapy candidate. The treatment is currently in Phase I/II development for the potential treatment of acute ...

Cell Medica boosts manufacturing capacity in cell therapy deal

The U.K. cell therapy company hopes to push forward with development of CGT Catapult's WT1 targeting T-cell receptor technology. 

Cell Medica Acquires WT1 Cancer Immunotherapy from CGT Catapult

NewsCGT Catapult has been developing the WT1-TCR cell therapy for the treatment of acute myeloid leukaemia and myelodysplastic syndrome.

Cell Medica buys clinical-phase cell therapy from Catapult

Catapult Therapy TCR and its Phase I/II Wilms' tumor 1 protein-T-cell receptor T-cell therapy candidate will be purchased by  -More- 

PubMed Articles [6033 Associated PubMed Articles listed on BioPortfolio]

Sarcomatoid Squamous Cell Carcinoma of the Penis - a Report of Two Cases.

Sarcomatoid (spindle cell) squamous cell carcinoma is a rare, highgrade, aggressive tumor consisting of the squamous cell carcinoma admixed with the malignant spindle cell (sarcomatoid) elements. Thes...

Investigation of P120catenin Expression in Human Basal Cell Carcinoma of the Skin.

P120(ctn) is a specific membranous adhesion protein, that maintains the stability of intercellular junctions. An altered expression of p120(ctn), either reduced in the cell membrane or increase in the...

Immune Cell Subsets Evaluation as a Predictive Tool for Hepatitis B Infection Outcome and Treatment Responsiveness.

The patient's immune response is one of the major factors influencing HBV eradication or chronification, and it is thought to be responsible for the treatment success.

Isolation and Structure Characterization of Cytotoxic Phorbol Esters from the Seeds of Croton tiglium.

Nine new and eleven known phorbol esters were isolated from an acetone extract of the seeds of Croton tiglium. Their structures were determined by extensive analysis of spectroscopic data. Eleven of t...

Multipotent Stem Cell and Current Application.

Stem cells are self-renewing and undifferentiated cell types that can be differentiate into functional cells. Stem cells can be classified into two main types based on their source of origin: Embryoni...

Clinical Trials [5193 Associated Clinical Trials listed on BioPortfolio]

Cardiovascular-Protective Effects of Herbal Medicine Danshen-Gegen

Atherosclerosis (in particular stroke and heart attack) is the most important health issue in modernized society and high blood pressure is an important predisposing factor. Hypertensive s...

The Study of Two Different Chinese Traditional Medicine Treatment on Chronic Hepatitis B

Although the incidence of Hepatitis B has been decreased a lot recently years, there are still quite a few chronic hepatitis B patients in China. The anti-virus drugs of western medicine s...

Interdisciplinary Case-Control Study of Bladder Cancer in Spain

The incidence rate of bladder cancer in the Barcelona area of Spain is almost identical to that of the U.S. Cigarette smoking has been identified as the most significant risk factor for b...

A Study for Patients With Non-Hodgkin's Lymphomas

In this study, all patients will get investigational drug. There will be no comparator drug. This study will evaluate three tumor types: T-cell lymphoma, Indolent B-cell lymphoma, and A...

Spectralis HRA+OCT Imaging of the Retina With Autofluorescence in Sickle Cell Disease

To determine the retinal and choroidal thickness in patients with sickle cell disease compared to age, race matched population without sickle cell disease to allow a better understanding o...

Companies [948 Associated Companies listed on BioPortfolio]

Cell Medica Limited

Cell Medica is a cellular therapeutics company engaged in the development, manufacturing and marketing of T cell immunotherapy approaches for the treatment of infections and cance...

Medica Corporation

Medica Corporation manufactures and sells in vitro diagnostic medical devices including electrolyte and blood gas analyzers, chemistry analyzers, and hematology analyzers. Medica ...

ASTA Medica GmbH

Wellcome to ASTA Medica In the course of the restructuring process of ASTA Medica, the business units AWD.pharma, Oncology and VIATRIS (Health Products) have been sold to other pharmaceutical companie...

International Medica Foundation

The International Medica Foundation, which has the rights to RotaShield, is a nonprofit foundation that focuses on ensuring that a safe, effective and affordable rotavirus ...

Medica

Medica is a health insurance company headquartered in Minneapolis and active in the Upper Midwest. With nearly 1.6 million members, the non-profit company provides health care cov...

More Information about "Cell Medica" on BioPortfolio

We have published hundreds of Cell Medica news stories on BioPortfolio along with dozens of Cell Medica Clinical Trials and PubMed Articles about Cell Medica for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cell Medica Companies in our database. You can also find out about relevant Cell Medica Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Immunology
Allergies Automimmune Disease Human Papillomavirus (HPV) Immunology Vaccine Immunology is the study of immunity and the defence mechanisms of the body. A greater understanding of immunology is needed to develop vaccines, understand ...

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...


Corporate Database Quicklinks



Searches Linking to this Company Record